Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma组蛋白甲基转移酶PRDM9促进胶质母细胞瘤中药物耐受持久性细胞的存活Nature CommunicationsIF15.72025-12-150OA
Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cellsCELL DEATH DISCOVERYIF72021-04-1631OAAI
MerTK activity is not necessary for the proliferation of glioblastoma stem cellsBIOCHEMICAL PHARMACOLOGYIF5.62021-04-013PREAI
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primatesSCIENCE ADVANCESIF12.52020-05-1533OAAI
MK2 inhibition stabilizes wild-type and mutated p53 in glioblastoma cells and leads to different cellular responsesMOLECULAR CANCER THERAPEUTICSIF5.52019-12-010PRE
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patientsACTA NEUROPATHOLOGICA COMMUNICATIONSIF5.72018-02-0819OAAI
Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's DiseaseMOLECULAR THERAPYIF122018-02-01105OAAI
In vivo models of alpha-synuclein transmission and propagationCELL AND TISSUE RESEARCHIF2.92017-11-2955PREAI
Role of micro RNAs in theRegulation of α-Synuclein Expression: A Systematic ReviewFRONTIERS IN MOLECULAR NEUROSCIENCEIF3.82016-11-2143OAAI
BAX channel activity mediates lysosomal disruption linked to Parkinson diseaseAUTOPHAGYIF14.32014-03-2672OAAI
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeysANNALS OF NEUROLOGYIF7.72014-02-18559PRE
Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiencyCELL DEATH AND DIFFERENTIATIONIF15.42012-08-0375OAAI